JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism

Vahid Tavakoli; Sundee Naing

doi:10.5045/br.2017.52.1.67

Quick links

Most Cited Most Read Ahead of Print Archives Go to E-submission

Letter to the Editor

Split Viewer

Blood Res 2017; 52(1):

Published online March 27, 2017

https://doi.org/10.5045/br.2017.52.1.67

JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism

Vahid Tavakoli^*, and Sundee Naing

Author Info. +

Department of Internal Medicine, Richmond University Medical Center, Staten Island, NY, USA.

Correspondence to : Vahid Tavakoli. Department of Internal Medicine, Richmond University Medical Center, 355 Bard Ave, Staten Island, NY 10310, USA. v_tavakoli@yahoo.com

Received: February 10, 2016; Revised: March 14, 2016; Accepted: April 14, 2016

Article

Letter to the Editor

Blood Res 2017; 52(1): 67-69

Published online March 27, 2017 https://doi.org/10.5045/br.2017.52.1.67

JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism

Vahid Tavakoli^*, and Sundee Naing

Department of Internal Medicine, Richmond University Medical Center, Staten Island, NY, USA.

Correspondence to: Vahid Tavakoli. Department of Internal Medicine, Richmond University Medical Center, 355 Bard Ave, Staten Island, NY 10310, USA. v_tavakoli@yahoo.com

Received: February 10, 2016; Revised: March 14, 2016; Accepted: April 14, 2016